Medicus Pharma Ltd (TSE:MDCX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Medicus Pharma Ltd has announced the pricing of its $4 million initial public offering in the U.S., with shares and warrants set to begin trading on Nasdaq. The company plans to use the funds to advance clinical trials for its innovative skinpatch treatment for basal cell carcinoma. The IPO is expected to close on November 15, 2024, under customary conditions, with Maxim Group LLC managing the offering.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.
